PubMed COVID-19 Clinical Care

Subjective, behavioral and neurobiological effects of cannabis and cannabinoids in social anxiety

Monday, October 09, 2023 - 4:00 AM

Social anxiety disorder (SAD) is a debilitating disorder, characterized by fear and anxiety in social situations. Evidence suggests that the levels of SAD are rising, in particularly after the COVID-19 pandemic. Serotonin and noradrenaline reuptake

A SARS-CoV-2 related signature that explores the tumor microenvironment and predicts immunotherapy response in esophageal squamous cell cancer

Monday, October 09, 2023 - 4:00 AM

CONCLUSION: The utilization of risk signatures based on SCRGs can efficiently forecast the prognosis of ESCC. A thorough characterization of the SCRGs signature in ESCC could facilitate the interpretation of ESCC's response to immunotherapy and offer

Comments on: Bacterial and fungal superinfections are detected at higher frequency in critically ill patients affected by SARS CoV-2 infection than negative patients and are associated to a worse outcome

Monday, October 09, 2023 - 4:00 AM

No abstract

Infection of Primary Nasal Epithelial Cells Grown at an Air-Liquid Interface to Characterize Human Coronavirus-Host Interactions

Monday, October 09, 2023 - 4:00 AM

Three highly pathogenic human coronaviruses (HCoVs) - SARS-CoV (2002), MERS-CoV (2012), and SARS-CoV-2 (2019) - have emerged and caused significant public health crises in the past 20 years. Four additional HCoVs cause a significant portion of common

The role of core self-evaluations and ego-resiliency in predicting resource losses and gains in the face of the COVID-19 crisis: the perspective of conservation of resources theory

Monday, October 09, 2023 - 4:00 AM

CONCLUSIONS: The results of this study highlight in particular the role of CSE as a protective factor of resource losses, and the role of ER as a promotive factor of resource gains, suggesting that both traits might evoke divergent resilience

The Association Between Increased Maladaptive Health Behaviours and Elevated Mental Health Symptoms Among Persons with IBD During the COVID-19 Pandemic

Monday, October 09, 2023 - 4:00 AM

CONCLUSION: During the COVID-19 pandemic, persons with IBD who experienced any maladaptive health behaviour was associated with double the likelihood of experiencing clinically significant MH symptoms. For persons with elevated MH symptoms, it is

Analysis of HBV and COVID-19 Coinfection Model with Intervention Strategies

Monday, October 09, 2023 - 4:00 AM

Coinfection of hepatitis B virus (HBV) and COVID-19 is a common public health problem throughout some nations in the world. In this study, a mathematical model for hepatitis B virus (HBV) and COVID-19 coinfection is constructed to investigate the

Multisystem inflammatory syndrome in a neonate secondary to COVID-19: a case report

Monday, October 09, 2023 - 4:00 AM

CONCLUSION: Multisystem inflammatory syndrome in neonates is rare but should always be considered in neonates with multisystem involvement and a history of maternal upper respiratory tract infection after excluding all other causes.

Frequency and Characteristics of Depression and Its Association with Diminished Quality of Life in a Cohort of Individuals with Post-Acute Sequelae of COVID-19

Monday, October 09, 2023 - 4:00 AM

CONCLUSION: Many individuals may experience depression after COVID-19 infection, with symptoms appearing to be predominately somatic in nature and correspond with COVID-19 illness severity.

In Silico and In Vitro Potential of FDA-Approved Drugs for Antimalarial Drug Repurposing against Plasmodium Serine Hydroxymethyltransferases

Monday, October 09, 2023 - 4:00 AM

Malaria has spread in many countries, with a 12% increase in deaths after the coronavirus disease 2019 pandemic. Malaria is one of the most concerning diseases in the Greater Mekong subregion, showing increased drug-resistant rates. Serine